FDA weighs fate of Qnexa for weight loss, again - KFDA

USA TODAYFDA weighs fate of Qnexa for weight loss, againKFDA21 (HealthDay News) -- The US Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects.FDA Says Weight Loss Drug Needs CV Outcome TrialFamily Practice News Digital NetworkFDA to review rejected weight loss drug QnexaNews-Medical.netPanel to ponder fate of weight-loss pillKTVQ Billings NewsSeeking Alpha -allvoices -1590 KLIV Silicon Valley Newsall 82 news articles »...

read more...

Share |

Published By: Weight-loss - Tuesday, 21 February